InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,458.55
(
-0.11%
)
US TECH 100
19,020.00
(
-0.97%
)
Dow Jones
39,391.71
(
0.62%
)
Brent Oil
85.33
(
1.55%
)
Bitcoin
60,197.97
(
-4.69%
)
Post# of 4972769
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

pumpnass

Send PM Follow Ignore
Followers 763
Posts 61539
Boards Moderated 0
Alias Born 02/18/2010

pumpnass

Re: None

Thursday, 01/26/2023 9:14:08 AM

Thursday, January 26, 2023 9:14:08 AM

Post# of 4972769
$NBIO 8K out from yesterday’s news

Nascent Biotech, Inc. (OTCQB: NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology company developing monoclonal antibodies that target various cancer types, issued a press release on January 25, 2023 announcing the completion of the dosing period of its Phase I Clinical Trial evaluating the safety and dose tolerance of Pritumumab (“PTB”) as a treatment for brain cancer.


https://www.otcmarkets.com/filing/html?id=16336218&guid=s22-ke4whc2pJth
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up